Advertisement

Spinal Tech

Mainstay Medical has received authorization from the Medicines and Healthcare Products Regulatory Agency and the Central Ethics Committee to expand the clinical trial of ReActiv8 to include clinical trial sites in the United Kingdom.

Advertisement
Advertisement